Chao Huang

Phase III Randomized Trial of Induction Chemotherapy in Patients With N2 or N3 Locally Advanced Head and Neck Cancer

Ezra E.W. Cohen, Theodore Karrison, Masha Kocherginsky et al. · Journal of Clinical Oncology · 2014 · 558 citations · Full text

DeCIDE: A phase III randomized trial of docetaxel (D), cisplatin (P), 5-fluorouracil (F) (TPF) induction chemotherapy (IC) in patients with N2/N3 locally advanced squamous cell carcinoma of the head and neck (SCCHN).

Ezra E.W. Cohen, Theodore Karrison, Masha Kocherginsky et al. · Journal of Clinical Oncology · 2012 · 135 citations

Squamous Cell Carcinoma, Same Crt, Pathology +19

Phase II Evaluation of Sorafenib in Advanced and Metastatic Squamous Cell Carcinoma of the Head and Neck: Southwest Oncology Group Study S0420

Stephen K. Williamson, James Moon, Chao Huang et al. · Journal of Clinical Oncology · 2010 · 110 citations · Full text

Delivery of a Liposomal <b> <i>c-raf-1</i> </b> Antisense Oligonucleotide by Weekly Bolus Dosing in Patients with Advanced Solid Tumors

Charles M. Rudin, John L. Marshall, Chao Huang et al. · Clinical Cancer Research · 2004 · 91 citations · Full text

Phase I study of liposome-encapsulated c-raf antisense oligodeoxyribonucleotide infusion in combination with radiation therapy in patients with advanced malignancies.

Anatoly Dritschilo, Chao Huang, Charles M. Rudin et al. · Clinical Cancer Research · 2006 · 87 citations